CRISPR Assays for Disease Diagnosis: Progress to and Barriers Remaining for Clinical Applications

Abstract: Numerous groups have employed the special properties of CRISPR/Cas systems to develop platforms that have broad potential applications for sensitive and specific detection of nucleic acid (NA) targets. However, few of these approaches have progressed to commercial or clinical applications. This review summarizes the properties of known CRISPR/Cas systems and their applications, challenges associated with the development of such assays, and opportunities to improve their performance or address unmet assay needs using nano‐/micro‐technology platforms. These include rapid and efficient sample preparation, integrated single‐tube, amplification‐free, quantifiable, multiplex, and non‐NA assays. Finally, this review discusses the current outlook for such assays, including remaining barriers for clinical or point‐of‐care applications and their commercial development.

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
CRISPR Assays for Disease Diagnosis: Progress to and Barriers Remaining for Clinical Applications ; day:10 ; month:05 ; year:2023 ; extent:16
Advanced science ; (10.05.2023) (gesamt 16)

Urheber
Huang, Zhen
Lyon, Christopher J.
Wang, Jin
Lu, Shuihua
Hu, Tony Y.

DOI
10.1002/advs.202301697
URN
urn:nbn:de:101:1-2023051015365577644903
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:53 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Beteiligte

  • Huang, Zhen
  • Lyon, Christopher J.
  • Wang, Jin
  • Lu, Shuihua
  • Hu, Tony Y.

Ähnliche Objekte (12)